The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2019

Filed:

Jun. 28, 2018
Applicant:

Feinstein Patents, Llc, Wilkes-Barre, PA (US);

Inventor:

Peter A. Feinstein, Palm Beach Gardens, FL (US);

Assignee:

Feinstein Patents, LLC, Wilkes-Barre, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61N 1/32 (2006.01); A61N 1/04 (2006.01); A61B 5/0408 (2006.01); A61B 5/00 (2006.01); A61N 1/378 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36114 (2013.01); A61B 5/0033 (2013.01); A61B 5/0408 (2013.01); A61N 1/0452 (2013.01); A61N 1/0456 (2013.01); A61N 1/323 (2013.01); A61N 1/36053 (2013.01); A61N 1/378 (2013.01);
Abstract

An interferential current system for cardiac treatment of a patient, includes a controller, a stimulation power supply and a plurality of electrodes. The electrodes supply transcutaneous electrical impulses when supplied power by the stimulation power supply, the plurality of electrodes including at least two electrodes supplying transcutaneous electrical impulses at two different frequencies, the transcutaneous electrical impulses provided at two different frequencies giving rise to at least one beat impulse having an interference frequency. At least one sensor in communication with the controller provides data to the controller indicative of various cardiac pathologic conditions, including but not limited to, rhythm abnormalities, muscle wall contraction abnormalities, and ischemic heart disease abnormalities of the patient. At least one of a timing and an intensity of the transcutaneous electrical impulses is varied by the controller based at least in part upon the data indicative of the aforementioned cardiac pathologies of the patient.


Find Patent Forward Citations

Loading…